PRP Female Hair Loss Study-Enrolling Patients
Dr Ken L. Williams of the Irvine Institute of Medicine and Cosmetic Surgery-OC Hair Restoration is enrolling female patients suffering from hair loss in a medical research study. The study is designed to evaluate the effect(s) of Platelet Rich Plasma (PRP) therapy on women with Female Pattern Hair Loss (FPHL). The medical study is university based and privately financially supported by the International Society Hair Restoration Surgery (ISHRS) and medical partners.
WHAT IS FPHL?
The term, FPHL, has emerged as the preferred medical term for hair loss in women. As opposed to the primary male hair loss diagnosis-Androgenetic Alopecia, FPHL is caused by multiple etiologies, and treatment options are considered more complicated. Hair loss in women negatively impacts women more than men with impaired social function, decrease self-esteem, and loss of confidence. In many cases, a accurate clinical diagnosis can be made and the hair loss condition treated medically or surgically.
The eligibility criteria are: 1) Female gender, 2) At least 18 years old, and 3) Ludwig II FPHL diagnosed by history, physical examination, and either biopsy or strong family history of female pattern hair loss as defined by two or more female relatives known to have a familiar Ludwig pattern of hair loss, without known disease.
UNIVERSITY SPONSORED HAIR LOSS STUDY
The study has been approved by the Office of Human Research Protections at the University of Houston to evaluate the effect of PRP upon the growth of the hair follicle. It is financially supported by a small grant from the ISHRS and is designed by Baylor University hair surgeon and principal investigator, Dr. Carlos Puig. In addition to Drs. Puig and Williams, also participating in the multisite study are Dr. Robert Reese from Edina, Minnesota; and Dr. Matt Leavitt of Maitland, Florida.
HAIR LOSS INDUSTRY PARTNERS
This female hair loss study is supported by Cytomedix, the manufacturer of the Autologel system that creates the wound healing and hair stimulating properties from PRP. The research is a multi-site study consisting of hair loss specialists located in the northeast, south, and western regions of the United States. The study is prospective, double blinded, and placebo controlled to increase scientific validity and reduce physician bias. The official title of the research is Pilot Study On The Effect of Autologel Platelet Rich Plasma Injections On Hair Growth In Patients With Female Pattern Hair Loss.
COST TO PATIENT
There is no cost to eligible patients and no reimbursement is available for enrolling in the study. If the study demonstrates a significant difference between the placebo and study group, all patients in the placebo group will receive without charge PRP therapy to induce hair growth.
If you are interested in participating in this medical study, and if you have been under the care of a dermatologist or hair loss specialist, you may be eligible to participate in this hair loss study. Your contact is Jackie Kusinsky at Jackie@iimcs.org or call (949) 333-2999.